Publications by authors named "Pablo Estrella-Porter"

Background: The COVID-19 pandemic has prompted a transformation of medical training. Although there were obvious medical education and social interaction challenges, e-learning presented some advantages, which may have generated medical curricula innovation and adjustments to novel technological methodologies. This study aims to generate consensuses among medical students regarding medical education provided during the pandemic in the resource-limited context of a Global South university.

View Article and Find Full Text PDF

Public funding of vaccines may enhance vaccination rates, co-administration, and timeliness. The impacts of including the serogroup B meningococcus vaccine (MenB) into the national immunisation schedule on vaccination rates, co-administration rates, and timeliness were assessed using a population-based pre-funding (2022) and post-funding (2023) study design. MenB vaccination rates improved after funding and were in line with previously funded vaccines.

View Article and Find Full Text PDF
Article Synopsis
  • Respiratory syncytial virus (RSV) is a major cause of illness and hospitalization in young children, particularly those under 1 year old.
  • In the Valencian Community of Spain, a new monoclonal antibody called nirsevimab was introduced for high-risk children and those under 6 months as a preventive measure for the 2023-2024 RSV season.
  • Preliminary results indicate that the immunization campaign achieved 88.5% coverage, with immunized children showing a threefold reduction in RSV incidence and lower hospitalization rates for respiratory infections compared to those who were not immunized.
View Article and Find Full Text PDF

On the 60 anniversary of the initiation of the polio vaccination campaign in Spain, the significant milestone in achieving disease control is highlighted. There has been a shift from an incidence of over 2,000 yearly cases in the 1960s to a sustained absence of wild poliovirus (WPV) since 1988. Despite the observed negative impact on polio vaccination coverage at the onset of the COVID-19 pandemic, these rates gradually recovered, reaching 98.

View Article and Find Full Text PDF